MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/mt.2008.15

Медицинская библиотека · Molecular therapy : the journal of the American Society of Gene Therapy · 2008

AAV vector-mediated reversal of hypoglycemia in canine and murine glycogen storage disease type Ia.

Koeberl Dwight D, Pinto Carlos, Sun Baodong, Li Songtao, Kozink Daniel M, Benjamin Daniel K, Demaster Amanda K, Kruse Meghan A, Vaughn Valerie, Hillman Steven, Bird Andrew, Jackson Mark, Brown Talmage, Kishnani Priya S, Chen Yuan-Tsong

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Glycogen storage disease type Ia (GSD-Ia) profoundly impairs glucose release by the liver due to glucose-6-phosphatase (G6Pase) deficiency. An adeno-associated virus (AAV) containing a small human G6Pase transgene was pseudotyped with AAV8 (AAV2/8) to optimize liver tropism. Survival was prolonged in 2-week-old G6Pase (-/-) mice by 600-fold fewer AAV2/8 vector particles (vp), in comparison to previous experiments involving this model (2 x 10(9) vp; 3 x 10(11) vp/kg). When the vector was pseudotyped with AAV1, survival was prolonged only at a higher dose (3 x 10(13) vp/kg). The AAV2/8 vector uniquely prevented hypoglycemia during fasting and fully corrected liver G6Pase deficiency in GSD-Ia mice and dogs. The AAV2/8 vector has prolonged survival in three GSD-Ia dogs to >11 months, which validated this strategy in the large animal model for GSD-Ia. Urinary biomarkers, including lactate and 3-hydroxybutyrate, were corrected by G6Pase expression solely in the liver. Glycogen accumulation in the liver was reduced almost to the normal level in vector-treated GSD-Ia mice and dogs, as was the hepatocyte growth factor (HGF) in GSD-Ia mice. These preclinical data demonstrated the efficacy of correcting hepatic G6Pase deficiency, and support the further preclinical development of AAV vector-mediated gene therapy for GSD-Ia.

Для цитирования: Koeberl Dwight D, Pinto Carlos, Sun Baodong, Li Songtao, Kozink Daniel M, Benjamin Daniel K, Demaster Amanda K, Kruse Meghan A, Vaughn Valerie, Hillman Steven, Bird Andrew, Jackson Mark, Brown Talmage, Kishnani Priya S, Chen Yuan-Tsong. AAV vector-mediated reversal of hypoglycemia in canine and murine glycogen storage disease type Ia.. Molecular therapy : the journal of the American Society of Gene Therapy. 2008. DOI: 10.1038/mt.2008.15.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.